ES2137055T3 - Preparado combinado que contiene (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico y amida de acido n-(4-trifluorometilfenil)-2-ciano-3-hidroxicrotonico. - Google Patents
Preparado combinado que contiene (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico y amida de acido n-(4-trifluorometilfenil)-2-ciano-3-hidroxicrotonico.Info
- Publication number
- ES2137055T3 ES2137055T3 ES97907081T ES97907081T ES2137055T3 ES 2137055 T3 ES2137055 T3 ES 2137055T3 ES 97907081 T ES97907081 T ES 97907081T ES 97907081 T ES97907081 T ES 97907081T ES 2137055 T3 ES2137055 T3 ES 2137055T3
- Authority
- ES
- Spain
- Prior art keywords
- acid
- methylisoxazole
- trifluoromethylphenyl
- carboxylic
- preparation containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title abstract 4
- -1 4-TRIFLUOROMETHYLPHENYL Chemical class 0.000 title abstract 2
- VQBXUKGMJCPBMF-UHFFFAOYSA-N 5-methyl-1,2-oxazole-4-carboxylic acid Chemical compound CC=1ON=CC=1C(O)=O VQBXUKGMJCPBMF-UHFFFAOYSA-N 0.000 title abstract 2
- 150000003931 anilides Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
UNA PREPARACION SOLIDA QUE CONTIENE (4 - TRIFLUOROMETIL) ANILIDA DEL ACIDO 5 - METILISOXAZOL - 4 - CARBOXILICO Y LA AMIDA DEL ACIDO N - (4 - TRIFLUOROMETILFENIL) - 2 - CIANO - 3 - HIDROXICROTONICO, PARA EL TRATAMIENTO DE ENFERMEDADES INMUNOLOGICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19610955A DE19610955A1 (de) | 1996-03-20 | 1996-03-20 | Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2137055T3 true ES2137055T3 (es) | 1999-12-01 |
Family
ID=7788856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97907081T Expired - Lifetime ES2137055T3 (es) | 1996-03-20 | 1997-03-07 | Preparado combinado que contiene (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico y amida de acido n-(4-trifluorometilfenil)-2-ciano-3-hidroxicrotonico. |
Country Status (23)
Country | Link |
---|---|
US (1) | US7071222B2 (es) |
EP (1) | EP0896537B1 (es) |
JP (1) | JP4206131B2 (es) |
KR (1) | KR100464693B1 (es) |
CN (1) | CN1141095C (es) |
AT (1) | ATE183393T1 (es) |
AU (1) | AU705692B2 (es) |
BG (1) | BG64189B1 (es) |
BR (1) | BR9708108A (es) |
CY (1) | CY2209B1 (es) |
CZ (1) | CZ289446B6 (es) |
DE (2) | DE19610955A1 (es) |
ES (1) | ES2137055T3 (es) |
GR (1) | GR3031637T3 (es) |
HK (1) | HK1018742A1 (es) |
HU (1) | HU226677B1 (es) |
NO (1) | NO315595B1 (es) |
NZ (1) | NZ331933A (es) |
PL (1) | PL188052B1 (es) |
RU (1) | RU2198655C2 (es) |
TR (1) | TR199801862T2 (es) |
UA (1) | UA46103C2 (es) |
WO (1) | WO1997034600A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6355678B1 (en) | 1998-06-29 | 2002-03-12 | Parker Hughes Institute | Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
DE19960443C2 (de) | 1999-12-15 | 2002-05-08 | Aventis Pharma Gmbh | Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen |
KR20020067545A (ko) * | 1999-12-16 | 2002-08-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 레플루노마이드의 신규 제조 방법 및 이의 신규 결정형 |
DE10112924A1 (de) * | 2001-03-13 | 2002-10-02 | Erich Eigenbrodt | 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate |
DE10112925A1 (de) * | 2001-03-13 | 2002-10-02 | Erich Eigenbrodt | Verwendung von Zuckerphosphaten, Zuckerphosphatanalogen, Aminosäuren, Aminosäureanalogen zur Modulation von Transaminasen und/oder der Assoziation p36/Malat Dehydrogenase |
US20040152772A1 (en) * | 2001-03-13 | 2004-08-05 | Erich Eigenbrodt | 1-butyric acid derivatives and the use thereof |
GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
MXPA04000224A (es) | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
ATE516284T1 (de) | 2002-12-23 | 2011-07-15 | 4Sc Ag | Aromatische verbindungen als entzündungshemmende, immunomodulatorische und antiproliferative mittel |
ES2319596B1 (es) * | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
EP2100881A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Pyrimidyl- or pyridinylaminobenzoic acid derivatives |
UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
EP2135610A1 (en) * | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
EP2314577A1 (en) | 2009-10-16 | 2011-04-27 | Almirall, S.A. | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
US8686048B2 (en) | 2010-05-06 | 2014-04-01 | Rhizen Pharmaceuticals Sa | Immunomodulator and anti-inflammatory compounds |
UA108760C2 (uk) | 2010-07-01 | 2015-06-10 | Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби | |
EP2444086A1 (en) | 2010-10-22 | 2012-04-25 | Almirall, S.A. | Combinations comprising DHODH inhibitors and COX inhibitors |
WO2012109329A2 (en) | 2011-02-08 | 2012-08-16 | Children's Medical Center Corporation | Methods for treatment of melanoma |
CN103755592A (zh) * | 2013-12-30 | 2014-04-30 | 镇江圣安医药有限公司 | (2z)-氰基-3-羟基-n-[4-(三氟甲基)苯基]-2-丁烯酰胺的衍生物及其应用 |
WO2018136009A1 (en) | 2017-01-20 | 2018-07-26 | Aslan Pharmaceuticals Pte Ltd | Combination therapy |
KR20200131249A (ko) | 2018-03-16 | 2020-11-23 | 이뮤닉 아게 | 항-염증제, 면역조절제 및 항-증식제로서의 신규한 칼슘 염 다형체 |
EP3900717A1 (en) | 2020-04-21 | 2021-10-27 | Immunic AG | Vidofludimus for use in the treatment or prevention of viral diseases |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268382A (en) | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
DK0527736T3 (da) | 1990-05-18 | 1997-10-20 | Hoechst Ag | Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler. |
DE4127737A1 (de) * | 1991-08-22 | 1993-02-25 | Hoechst Ag | Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen |
US5519042A (en) | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
DE19908527C2 (de) | 1999-02-26 | 2001-08-30 | Aventis Pharma Gmbh | Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid |
-
1996
- 1996-03-20 DE DE19610955A patent/DE19610955A1/de not_active Withdrawn
-
1997
- 1997-03-07 AU AU19261/97A patent/AU705692B2/en not_active Expired
- 1997-03-07 HU HU9902130A patent/HU226677B1/hu unknown
- 1997-03-07 PL PL97328998A patent/PL188052B1/pl unknown
- 1997-03-07 ES ES97907081T patent/ES2137055T3/es not_active Expired - Lifetime
- 1997-03-07 KR KR10-1998-0707520A patent/KR100464693B1/ko not_active IP Right Cessation
- 1997-03-07 JP JP53309597A patent/JP4206131B2/ja not_active Expired - Lifetime
- 1997-03-07 RU RU98119285/14A patent/RU2198655C2/ru active
- 1997-03-07 EP EP97907081A patent/EP0896537B1/de not_active Expired - Lifetime
- 1997-03-07 US US09/101,672 patent/US7071222B2/en not_active Expired - Lifetime
- 1997-03-07 UA UA98105468A patent/UA46103C2/uk unknown
- 1997-03-07 BR BR9708108A patent/BR9708108A/pt active IP Right Grant
- 1997-03-07 DE DE59700356T patent/DE59700356D1/de not_active Expired - Lifetime
- 1997-03-07 WO PCT/EP1997/001167 patent/WO1997034600A1/de active IP Right Grant
- 1997-03-07 NZ NZ331933A patent/NZ331933A/en not_active IP Right Cessation
- 1997-03-07 TR TR1998/01862T patent/TR199801862T2/xx unknown
- 1997-03-07 CZ CZ19982985A patent/CZ289446B6/cs not_active IP Right Cessation
- 1997-03-07 AT AT97907081T patent/ATE183393T1/de active
- 1997-03-07 CN CNB971930414A patent/CN1141095C/zh not_active Expired - Lifetime
-
1998
- 1998-08-17 BG BG102697A patent/BG64189B1/bg unknown
- 1998-09-18 NO NO19984343A patent/NO315595B1/no not_active IP Right Cessation
-
1999
- 1999-08-27 HK HK99103705A patent/HK1018742A1/xx not_active IP Right Cessation
- 1999-10-27 GR GR990402726T patent/GR3031637T3/el unknown
-
2000
- 2000-12-01 CY CY0000065A patent/CY2209B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2137055T3 (es) | Preparado combinado que contiene (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico y amida de acido n-(4-trifluorometilfenil)-2-ciano-3-hidroxicrotonico. | |
CS145091A3 (en) | Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application | |
ES2183935T3 (es) | Isoxazoles sustituidos para el tratamiento de la inflamacion. | |
ES2147230T3 (es) | Derivados de aminoacidos, medicamentos que contienen a estos compuestos y procedimiento para su preparacion. | |
ES2124800T3 (es) | Empleo de leflunomida para la inhibicion de interleuquina 1 beta. | |
MX9101526A (es) | Nuevo metodo para tratar la depresion | |
HUP9900511A2 (hu) | Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás | |
PT99435A (pt) | Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem | |
DK0607777T3 (da) | Anvendelse af leflunomid til inhibering af interleukin 8 | |
ES542061A0 (es) | Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas | |
NO872671D0 (no) | 4-benzyloksy-3-pyrrolin-2-on-1-yl-acetamid, fremstilling og anvendelse derav. | |
HUP0004510A1 (hu) | Eljárás L-dihidroorotsav előállítására és a vegyület alkalmazása | |
PT83253B (pt) | Processo para a preparacao de p-acilaminobenzamidas | |
PT1000067E (pt) | Tiazolobenzo-heterociclos sua preparacao e medicamentos que os contem | |
NO970185L (no) | Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi | |
HUP9903892A2 (hu) | Hidroxámsavszármazékok | |
ES2049700T3 (es) | Sal de la s-carboximetilcisteina lisina monohidratada y procedimiento para su fabricacion. | |
FI934468A (fi) | Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytes mellanprodukter | |
ES2061891T3 (es) | Cristales de dihidrato de dihidrocloruro de compuesto de etoposido-2-dimetilamina y un procedimiento para su produccion. | |
BR9813037A (pt) | Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa | |
ES2182177T3 (es) | Procedimiento para la obtencion de acido 3,3-dimetilbutirico. | |
NO890245D0 (no) | Isoxazoler med nootrop aktivitet. | |
PT87644A (pt) | Process for preparing cardiovascularly active n,n'-dimethyl-n-(3,4,5-trimethoxybenzyl)-n'-<3,3-di-(4-fluorophenyl)-propyl>-ethylenediamine | |
JPS53103447A (en) | N-benzoyl-n'-phenoxyphenylureas and insecticides containing the same | |
ES2058378T3 (es) | Agente antiinflamatorio para terapia de hipertrofia prostatica, procedimiento para su preparacion y compuestos farmaceuticos que lo contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 896537 Country of ref document: ES |